1-Iodobicyclo[1.1.1]pentane reacts cleanly with t-butyllithium by a metal-halogen exchange process to give 1-lithiobicyclo[1.1.1]pentane. Both 1-chlorobicyclo[1.1.1]pentane and the parent hydrocarbon bicyclo [1.1.1]pentane are found to be inert to t-butyllithium.
Multipath couplings involving 1H-1H, and
13C-13C nuclei in a variety of 1-substituted bicycloalkanes are treated according to additivity principles based on empirical coupling increments derived from model hydrocarbons. The coupling constants are essentially additive in practically all series except for derivatives of bicyclo [1.1.1]pentane; non-additivities of several couplings in the latter are ascribed to the effects of contributions arising from through-space bridgehead-bridgehead interactions, as well as from mutual electronic perturbations between the different pathways. The results are compared with those derived previously from theoretical calculations, which also have some difficulty in reproducing the experimental data in the case of the bicyclo [1.1.1] pentyl system.
A series of dimercury(1) complexes of the type [Hg2L2]
[ClO4]2 has been prepared with heterocyclic nitrogen
donor ligands. Complexes with 2-ethylpyridine and 4-benzylpyridine were of the
form [Hg2L3.7] [ClO4]2 and [Hg2L4]
[ClO4]2 respectively. The formation of a stable complex
is found to be dependent on the effective base strength of the ligand.
1-Bromobicyclo[1.1.1]pentane (3) is found to undergo solvolysis faster than t-butyl bromide in 80% aqueous ethanol, and gives 3-methylenecyclobutanol (7) exclusively. Products arising from capture of the bicyclo[1.1.1] pentyl cation (5) were not detected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.